Sun Pharmaceutical Industries Limited said on 12 October 2026 that Gautam Doshi has tendered his resignation as a Non-Executive Independent Director with immediate effect, citing personal commitments. He has confirmed that there are no material reasons beyond those stated, and accordingly he has ceased to hold positions on the company’s board committees.
The board acknowledged the resignation and placed on record its sincere appreciation for Doshi’s valuable guidance and contributions during his tenure as an Independent Director of the company.
Doshi’s departure marks a moment of leadership transition for Sun Pharma as it continues to draw on independent oversight to steer governance and strategic decision-making in a rapidly evolving industry.